July 11th, 2023

FOR IMMEDIATE RELEASE 2023-128 Washington D.C. / CRWE PRESS RELEASE / July 11, 2023   -   The Securities and Exchange Commission today announced charges against Merrill Lynch, Pierce, Fenner & Smith Incorporated and its parent. Read more

July 11th, 2023

Byrna Technologies Inc. (Nasdaq: BYRN) reported a second-quarter fiscal 2023 loss of $0.05 per share and revenue of $11.51 million. These figures fell short of the consensus estimate, which projected earnings per share of $0.01 on revenue of $12 mill. Read more

July 11th, 2023

Astellas Pharma Inc. and 4D Molecular Therapeutics, Inc. (Nasdaq: FDMT)(4DMT) have entered into a license agreement, allowing the use of 4DMT's intravitreal retinotropic R100 vector for rare monogenic ophthalmic diseases. This includes one initial ge. Read more

July 11th, 2023

Shares of Better Therapeutics, Inc. (Nasdaq: BTTX) surged over 20% in after-hours trading as the company received authorization from the FDA for its groundbreaking prescription-only digital therapeutic, AspyreRx. This innovative treatment offers cogn. Read more

July 10th, 2023

CalAmp Corp. (Nasdaq: CAMP) faced a first-quarter fiscal 2024 loss of $0.11 per share, falling short of the consensus earnings per share estimate of $0.04. Looking ahead, the company expects Q2 FY24 revenues to range between $67 million and $73 mi. Read more

July 10th, 2023

Shares of Mobilicom Limited (Nasdaq: MOB) climbed over 100% in early trade following the company's announcement of a significant commercial-scale purchase order from Teledyne-FLIR, one of its Tier-1 customers. The purchase order from Teledyne Tech. Read more

July 10th, 2023

Shares of FMC Corporation (NYSE: FMC) plummeted over 6% following the release of an update on its second quarter and full-year 2023 outlook. The company now expects second-quarter revenue to be in the range of $1.00 billion to $1.03 billion, signific. Read more

July 10th, 2023

Helen of Troy Limited (Nasdaq: HELE) reported first-quarter fiscal 2024 adjusted earnings per share (EPS) of $1.94, surpassing the consensus estimate of $1.60. Looking ahead, for the full-year fiscal 2024, the company expects adjusted EPS to fall . Read more

July 10th, 2023

NanoString Technologies, Inc. (Nasdaq: NSTG) has reported strong preliminary financial figures for the second quarter of 2023. The company expects Q2 revenue to surpass $44 million, reflecting a remarkable year-on-year growth of approximately 37%. Th. Read more

July 10th, 2023

Shares of Nanobiotix S.A. (Nasdaq: NBTX) surged over 50% in pre-market trading following the announcement of a global licensing and commercialization agreement with Janssen Pharmaceutica NV, a subsidiary of Johnson & Johnson (NYSE: JNJ). The agree. Read more